MDPV - An Overview
There would appear being similarities involving the metabolism of α-PVP in rats and people (aside from four-hydroxylation) and consistency amongst different experiments with humans.MDPV was first designed in the sixties by a team at Boehringer Ingelheim.[one] It had been claimed to own prospective being an alternative for racemic amphetamine and,